Glenmark Pharmaceuticals Limited GLENMARK.NS
GLENMARK.NS
Glenmark Pharmaceuticals Limited LAURUSLABS.BO
Laurus Labs Limited LAURUSLABS.NS
Laurus Labs Limited AUROPHARMA.BO
Aurobindo Pharma Limited AUROPHARMA.NS
Aurobindo Pharma Limited ALKEM.NS
Alkem Laboratories Limited ALKEM.BO
Alkem Laboratories Limited GLAXO.BO
GlaxoSmithKline Pharmaceuticals Limited GLAXO.NS
GlaxoSmithKline Pharmaceuticals Limited COHANCE.NS
Cohance Lifesciences Limited
Glenmark Pharmaceuticals Limited LAURUSLABS.BO
Laurus Labs Limited LAURUSLABS.NS
Laurus Labs Limited AUROPHARMA.BO
Aurobindo Pharma Limited AUROPHARMA.NS
Aurobindo Pharma Limited ALKEM.NS
Alkem Laboratories Limited ALKEM.BO
Alkem Laboratories Limited GLAXO.BO
GlaxoSmithKline Pharmaceuticals Limited GLAXO.NS
GlaxoSmithKline Pharmaceuticals Limited COHANCE.NS
Cohance Lifesciences Limited
Performance
| Periode | GLENMARK.NS | LAURUSLABS.BO | LAURUSLABS.NS | AUROPHARMA.BO | AUROPHARMA.NS | ALKEM.NS | ALKEM.BO | GLAXO.BO | GLAXO.NS | COHANCE.NS |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 33.41 % | 41.77 % | 41.77 % | -7.33 % | -7.34 % | 10.65 % | 10.72 % | -1.65 % | -1.80 % | -26.97 % |
| YTD | 14.92 % | 50.21 % | 50.07 % | -18.53 % | -18.68 % | -0.42 % | -0.42 % | 23.62 % | 23.60 % | -19.97 % |
| 1Y | 10.29 % | 106.12 % | 106.00 % | -23.89 % | -23.98 % | -9.21 % | -9.05 % | 6.98 % | 6.98 % | -28.50 % |
| 3Y | 366.30 % | 92.57 % | 92.56 % | 109.97 % | 109.82 % | 78.68 % | 79.16 % | 101.11 % | 100.88 % | 118.22 % |
| 5Y | 280.87 % | 174.59 % | 175.09 % | 40.71 % | 40.69 % | 111.85 % | 111.68 % | 82.31 % | 82.73 % | 161.86 % |
| 10Y | 80.39 % | 861.34 % | 861.59 % | 33.25 % | 33.07 % | 301.50 % | 301.78 % | 66.80 % | 66.14 % | 433.04 % |
| Depuis le début | 6 741.45 % | 861.34 % | 861.59 % | 2 625.25 % | 5 242.23 % | 301.50 % | 301.78 % | 599.95 % | 797.17 % | 433.04 % |